Curis
CRIS
#10342
Rank
S$23.94 M
Marketcap
S$0.61
Share price
-2.08%
Change (1 day)
-77.19%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$54.75 Million, an increase over its 2023 earnings that were of -S$58.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-21.67%
2024 -S$54.75 Million-5.77%
2023 -S$58.1 Million-13.1%
2022 -S$66.86 Million27.52%
2021 -S$52.43 Million65.09%
2020 -S$31.76 Million-9.1%
2019 -S$34.94 Million-4.73%
2018 -S$36.67 Million-41.95%
2017 -S$63.17 Million-14.37%
2016 -S$73.77 Million3.55%
2015 -S$71.24 Million271.52%
2014 -S$19.18 Million76.64%
2013 -S$10.86 Million
2011 -S$9.22 Million27.76%
2010 -S$7.22 Million-43.87%
2009 -S$12.86 Million-23.44%
2008 -S$16.8 Million56.66%
2007 -S$10.72 Million-16.71%
2006 -S$12.87 Million-36.92%
2005 -S$20.41 Million156.25%
2004 -S$7.97 Million-37.24%
2003 -S$12.69 Million-93.34%
2002 -S$0.2 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.55 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.28 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$79.21 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.28 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.7 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA